• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苏氨酸18,γ-甲基亮氨酸19]内皮素-1在人内皮素受体中的拮抗活性

Antagonist activity of [Thr18,gamma-methylleucine19]endothelin-1 in human endothelin receptors.

作者信息

Masuda Y, Sugo T, Kikuchi T, Satoh M, Fujisawa Y, Itoh Y, Wakimasu M, Ohtaki T

机构信息

Discovery Research Laboratories I, Takeda Chemical Industries, Ltd., Tsukuba, Ibaraki, Japan.

出版信息

Eur J Pharmacol. 1997 May 1;325(2-3):263-70. doi: 10.1016/s0014-2999(97)00130-1.

DOI:10.1016/s0014-2999(97)00130-1
PMID:9163574
Abstract

Receptor binding and antagonist properties of endothelin-1 analogues, [Thr18,gamma-methylleucine19]endothelin-1, [Thr18,Leu19]endothelin-1 and [Thr18,cyclohexylalanine19]endothelin-1, were investigated using cloned human endothelin ET(A) and ET(B) receptors expressed in Chinese hamster ovary cells. Among them, [Thr18,gamma-methylleucine19]endothelin-1 had a high affinity for endothelin ET(A) and ET(B) receptors with respective Kd values of 300 and 110 pM and had no agonist activity on the stimulation of arachidonic acid release in endothelin ET(A) and ET(B) receptor-expressing cells. [Thr18,gamma-methylleucine19]Endothelin-1 had potent antagonist activity in endothelin-1-induced arachidonic acid release in endothelin ET(A) and ET(B) receptor-expressing cells with respective pA2 values of 8.2 and 8.5. In an inositol phosphates accumulation assay, [Thr18,gamma-methylleucine19]endothelin-1 also exhibited potent antagonist activity for endothelin ET(A) and ET(B) receptors with respective pA2 values of 8.0 and 8.4. In conclusion, [Thr18,gamma-methylleucine19]endothelin-1 acts as a potent and nonselective antagonist with no agonist activity for cloned human endothelin ET(A) and ET(B) receptors.

摘要

使用在中国仓鼠卵巢细胞中表达的克隆人内皮素ET(A)和ET(B)受体,研究了内皮素-1类似物[Thr18,γ-甲基亮氨酸19]内皮素-1、[Thr18,亮氨酸19]内皮素-1和[Thr18,环己基丙氨酸19]内皮素-1的受体结合及拮抗剂特性。其中,[Thr18,γ-甲基亮氨酸19]内皮素-1对内皮素ET(A)和ET(B)受体具有高亲和力,其Kd值分别为300和110 pM,并且对表达内皮素ET(A)和ET(B)受体的细胞中花生四烯酸释放的刺激没有激动剂活性。[Thr18,γ-甲基亮氨酸19]内皮素-1在表达内皮素ET(A)和ET(B)受体的细胞中,对内皮素-1诱导的花生四烯酸释放具有强效拮抗剂活性,其pA2值分别为8.2和8.5。在肌醇磷酸积累试验中,[Thr18,γ-甲基亮氨酸19]内皮素-1对内皮素ET(A)和ET(B)受体也表现出强效拮抗剂活性,其pA2值分别为8.0和8.4。总之,[Thr18,γ-甲基亮氨酸19]内皮素-1对克隆的人内皮素ET(A)和ET(B)受体起强效非选择性拮抗剂作用,且无激动剂活性。

相似文献

1
Antagonist activity of [Thr18,gamma-methylleucine19]endothelin-1 in human endothelin receptors.[苏氨酸18,γ-甲基亮氨酸19]内皮素-1在人内皮素受体中的拮抗活性
Eur J Pharmacol. 1997 May 1;325(2-3):263-70. doi: 10.1016/s0014-2999(97)00130-1.
2
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.J-104132(L-753,037)的药理学特性,一种强效、口服活性的ETA/ETB内皮素受体混合拮抗剂。
J Pharmacol Exp Ther. 1999 Jun;289(3):1262-70.
3
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies.内皮素受体拮抗剂ABT-627、ABT-546、A-182086和A-192621的药理学:体外研究
Clin Sci (Lond). 2002 Aug;103 Suppl 48:107S-111S. doi: 10.1042/CS103S107S.
4
Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.新型内皮素受体拮抗剂TAK-044[环[D-α-天冬氨酰-3-[(4-苯基哌嗪-1-基)羰基]-L-丙氨酰-L-α-天冬氨酰-D-2-(2-噻吩基)甘氨酰-L-亮氨酰-D-色氨酰]二钠盐]在人内皮素A和内皮素B受体中的受体结合及拮抗剂特性
J Pharmacol Exp Ther. 1996 Nov;279(2):675-85.
5
Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.新型内皮素拮抗剂FR139317对转染的中国仓鼠卵巢细胞中两种内皮素受体的亚型选择性。
Mol Pharmacol. 1993 Feb;43(2):127-31.
6
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist.
Life Sci. 1996;58(14):1149-57. doi: 10.1016/0024-3205(96)00073-2.
7
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.A-216546的药理学:一种内皮素ET(A)受体的高选择性拮抗剂。
Eur J Pharmacol. 1999 Feb 5;366(2-3):189-201. doi: 10.1016/s0014-2999(98)00891-7.
8
Conversion of big-endothelin-1 elicits an endothelin ETA receptor-mediated response in endothelial cells.大内皮素-1的转化在内皮细胞中引发内皮素ETA受体介导的反应。
Eur J Pharmacol. 1997 Mar 5;321(3):387-96. doi: 10.1016/s0014-2999(96)00973-9.
9
Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.在第18位和第19位均被取代的内皮素-1类似物:高效的内皮素拮抗剂,对ETA或ETB受体亚型均无选择性。
J Med Chem. 1993 Dec 10;36(25):4087-93. doi: 10.1021/jm00077a013.
10
ET(A) and ET(B) specific ligands synergistically antagonize endothelin-1 binding to an atypical endothelin receptor in primary rat astrocytes.ET(A)和ET(B)特异性配体协同拮抗内皮素-1与原代大鼠星形胶质细胞中非典型内皮素受体的结合。
J Neurochem. 1998 Feb;70(2):473-82. doi: 10.1046/j.1471-4159.1998.70020473.x.